Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cognos Therapeutics

Cognos Therapeutics
2015 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE
$117K LATEST DEAL AMOUNT
Description

Developer of diagnostic and drug delivery devices deigned to detect diseases and deliver drugs. The company's diagnostic and drug delivery devices radically advance the diagnosis and treatment of neuropathic diseases including tumor-based brain and spinal cancers, degenerative cognition disorders, cerebral trauma occurrences as well as other Central Nervous System afflictions, enabling doctors to detect diseases, monitor their patients and deliver medicines as per requirements.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Monitoring Equipment
Primary Office
  • 10604 South La Cienega Boulevard
  • Inglewood, CA 90304
  • United States

+1 (310) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cognos Therapeutics’s full profile, request a free trial.

Cognos Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 29-May-2018 $117K 00000 Completed Startup
2. Angel (individual) 20-Apr-2016 0000 00000 Completed Startup
1. Angel (individual) 07-Dec-2015 $160K $160K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cognos Therapeutics Executive Team (9)

Name Title Board
Seat
Contact
Info
Frank Adell Chief Executive Officer & Board Member
Thomas Lobl Ph.D Chief Operating Officer
Winston Wu Chief Technology Officer & Senior Vice President of Product Development
Ian Welsford Ph.D Chief Regulatory and Compliance Office
Josh Shachar Chief Innovation Officer & Board Member

2 Former Executives

You’re viewing 5 of 9 executives. Get the full list »

Cognos Therapeutics Board Members (8)

Name Representing Role Since Contact
Info
Eli Gang Cognos Therapeutics Board Member 000 0000
Frank Adell Cognos Therapeutics Chief Executive Officer & Board Member 000 0000
Josh Shachar Cognos Therapeutics Chief Innovation Officer & Board Member 000 0000
Richard Lerner MD Cognos Therapeutics Board Member 000 0000
Roger Kornberg Ph.D Cognos Therapeutics Chairman 000 0000

2 Former Board Members

You’re viewing 5 of 8 board members. Get the full list »